Assessment of Early Growth Response 1 in Tumor Suppression of Esophageal Squamous Cell Carcinoma
暂无分享,去创建一个
H. Hsu | Y. Goan | Ching-Juinn Tseng | Y. Tseng | Chih-Wen Shu | Yi-Hsuan Lin | Yen-Chiang Tseng | Hui-Min Chang
[1] Md. Saiful Islam,et al. Prognostic role of EGR1 in breast cancer: a systematic review , 2021, BMB reports.
[2] Darui Wang,et al. Egr‑1 inhibits colon cancer cell proliferation, migration and invasion via regulating CDKL1 at the transcriptional level. , 2021, Oncology reports.
[3] T. Sunkara,et al. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors , 2020, Clinical Journal of Gastroenterology.
[4] Wei Zhang,et al. miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB , 2020, Cancer management and research.
[5] Wanhai Xu,et al. EGR1 Regulates Angiogenic and Osteoclastogenic Factors in Prostate Cancer and Promotes Metastasis , 2019, Oncogene.
[6] Ling Lin,et al. TCF7L2 and EGR1 synergistic activation of transcription of LCN2 via an ERK1/2-dependent pathway in esophageal squamous cell carcinoma cells. , 2019, Cellular signalling.
[7] Kangdong Liu,et al. α-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA‑138 expression. , 2018, Oncology reports.
[8] K. Liang,et al. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma , 2017, Yonsei medical journal.
[9] Kunming Zhao,et al. EGR-1/ASPP1 inter-regulatory loop promotes apoptosis by inhibiting cyto-protective autophagy , 2017, Cell Death & Disease.
[10] Chi Zhang,et al. A novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cell line Eca-109/5-FU with significant drug resistance-related characteristics. , 2017, Oncology reports.
[11] Dongqing Wang,et al. Cisplatin-based chemoradiotherapy with 5-fluorouracil or pemetrexed in patients with locally advanced, unresectable esophageal squamous cell carcinoma: A retrospective analysis. , 2017, Molecular and clinical oncology.
[12] Zhao-lu Kong,et al. Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells , 2017, International journal of radiation biology.
[13] L. Lan,et al. Paclitaxel induces apoptosis of esophageal squamous cell carcinoma cells by downregulating STAT3 phosphorylation at Ser727. , 2017, Oncology reports.
[14] D. Pei,et al. Egr-1 suppresses breast cancer cells proliferation by arresting cell cycle progression via down-regulating CyclinDs. , 2017, International journal of clinical and experimental pathology.
[15] A. Shelling,et al. A novel EGR‐1 dependent mechanism for YB‐1 modulation of paclitaxel response in a triple negative breast cancer cell line , 2016, International journal of cancer.
[16] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[17] H. Hsu,et al. The 4E-BP1/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells. , 2015, The Journal of thoracic and cardiovascular surgery.
[18] Su-Hyung Hong,et al. Early growth response protein 1 upregulation and nuclear translocation by 2'-benzoyloxycinnamaldehyde induces prostate cancer cell death. , 2013, Cancer letters.
[19] P. Leung,et al. Egr-1 mediates epidermal growth factor-induced downregulation of E-cadherin expression via Slug in human ovarian cancer cells , 2013, Oncogene.
[20] E. Parra,et al. The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines. , 2010, Oncology reports.
[21] Na Xu,et al. Hypoxia Stabilizes Microtubule Networks and Decreases Tumor Cell Chemosensitivity to Anticancer Drugs Through Egr‐1 , 2010, Anatomical record.
[22] W. Hsu,et al. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus. , 2008, The Journal of thoracic and cardiovascular surgery.
[23] F. Wamunyokoli,et al. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. , 2006, Cancer research.
[24] D. Mercola,et al. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin , 2006, Cancer Gene Therapy.
[25] Dan Mercola,et al. Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. , 2005, Cancer research.
[26] Huan-Xing Yang,et al. Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study. , 2004, World journal of gastroenterology.
[27] A. Porcellini,et al. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[28] P. Humphrey,et al. Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. , 2001, Human pathology.
[29] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[30] D. Tindall,et al. Expression of early growth response genes in human prostate cancer. , 1998, Cancer research.
[31] D. Mercola,et al. Decreased Egr‐1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation , 1997, International journal of cancer.
[32] R. Figlin,et al. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. , 1995, Oncogene.
[33] H. Takano,et al. Different sensitivities of human esophageal cancer cells to multiple anti‐cancer agents and related mechanisms , 1992, Cancer.